N+1 Singer Reiterates Corporate Rating for Futura Medical plc. (FUM)
Futura Medical plc. (LON:FUM)‘s stock had its “corporate” rating reissued by stock analysts at N+1 Singer in a report issued on Thursday.
Shares of Futura Medical plc. (LON:FUM) opened at 64.89999 on Thursday. The company’s market cap is GBX 64.31 million. The company has a 50-day moving average of GBX 56.33 and a 200 day moving average of GBX 29.32. Futura Medical plc. has a 12 month low of GBX 14.31 and a 12 month high of GBX 95.60.
About Futura Medical plc.
Futura Medical plc is a United Kingdom-based pharmaceutical company that develops products for consumer healthcare. The Company is engaged in the research and development of pharmaceutical drugs and medical devices and the commercial exploitation. It is also engaged in transdermal delivery and has developed a transdermal technology, DermaSys for the absorption of active molecules through the skin.
Receive News & Stock Ratings for Futura Medical plc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Futura Medical plc. and related stocks with our FREE daily email newsletter.